# Screening for Brain Metastases

> **NCT07492121** · PHASE2 · NOT_YET_RECRUITING · sponsor: **University of Zurich** · enrollment: 180 (estimated)

## Conditions studied

- Lung Cancer Stage IV
- Melanoma Stage IV
- Breast Cancer Metastatic

## Interventions

- **OTHER:** gadopiclenol (contrast agent)
- **OTHER:** standard contrast agent

## Key facts

- **NCT ID:** NCT07492121
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09
- **Primary completion:** 2029-06
- **Final completion:** 2030-01
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2026-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07492121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07492121, "Screening for Brain Metastases". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT07492121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*